KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Invested Capital (2016 - 2025)

Historic Invested Capital for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $3.3 billion.

  • West Pharmaceutical Services' Invested Capital rose 1013.64% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year increase of 1013.64%. This contributed to the annual value of $2.9 billion for FY2024, which is 657.1% down from last year.
  • According to the latest figures from Q3 2025, West Pharmaceutical Services' Invested Capital is $3.3 billion, which was up 1013.64% from $3.1 billion recorded in Q2 2025.
  • West Pharmaceutical Services' Invested Capital's 5-year high stood at $3.3 billion during Q3 2025, with a 5-year trough of $2.1 billion in Q1 2021.
  • Over the past 5 years, West Pharmaceutical Services' median Invested Capital value was $2.9 billion (recorded in 2025), while the average stood at $2.8 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 2439.99% in 2021, then tumbled by 657.1% in 2024.
  • West Pharmaceutical Services' Invested Capital (Quarter) stood at $2.6 billion in 2021, then grew by 11.8% to $2.9 billion in 2022, then rose by 6.7% to $3.1 billion in 2023, then dropped by 6.57% to $2.9 billion in 2024, then increased by 12.8% to $3.3 billion in 2025.
  • Its Invested Capital was $3.3 billion in Q3 2025, compared to $3.1 billion in Q2 2025 and $2.9 billion in Q1 2025.